These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2137110)

  • 1. Purification and characterization of the extracellular C3d-binding protein of Candida albicans.
    Saxena A; Calderone R
    Infect Immun; 1990 Feb; 58(2):309-14. PubMed ID: 2137110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of the functionally active complement receptor for iC3b but not for C3d on an avirulent mutant of Candida albicans.
    Ollert MW; Wadsworth E; Calderone RA
    Infect Immun; 1990 Apr; 58(4):909-13. PubMed ID: 2138588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida albicans C3d receptor, isolated by using a monoclonal antibody.
    Linehan L; Wadsworth E; Calderone R
    Infect Immun; 1988 Aug; 56(8):1981-6. PubMed ID: 2969374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of C3d receptors on Candida albicans.
    Calderone RA; Linehan L; Wadsworth E; Sandberg AL
    Infect Immun; 1988 Jan; 56(1):252-8. PubMed ID: 2961702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of avirulent clones of Candida albicans with reduced ability to recognize the CR2 ligand C3d.
    Franzke S; Calderone RA; Schaller K
    Infect Immun; 1993 Jun; 61(6):2662-9. PubMed ID: 8500905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for expression of the C3d receptor of Candida albicans in vitro and in vivo obtained by immunofluorescence and immunoelectron microscopy.
    Kanbe T; Li RK; Wadsworth E; Calderone RA; Cutler JE
    Infect Immun; 1991 May; 59(5):1832-8. PubMed ID: 1826896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the C3d-binding protein (CR2) from Candida albicans during experimental candidiasis as measured by lymphoblastogenesis.
    Fukayama M; Wadsworth E; Calderone R
    Infect Immun; 1992 Jan; 60(1):8-12. PubMed ID: 1370279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mannoproteins from blastoconidia and hyphae of Candida albicans with a common epitope recognized by anti-complement receptor type 2 antibodies.
    Wadsworth E; Prasad SC; Calderone R
    Infect Immun; 1993 Nov; 61(11):4675-81. PubMed ID: 7691755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies.
    Barel M; Fiandino A; Lyamani F; Frade R
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10054-8. PubMed ID: 2557614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
    Iida K; Nadler L; Nussenzweig V
    J Exp Med; 1983 Oct; 158(4):1021-33. PubMed ID: 6225820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.
    Lambris JD; Dobson NJ; Ross GD
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1828-32. PubMed ID: 6101236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and antigenic analysis of the Epstein Barr virus/C3d receptor (CR2).
    Siaw MF; Nemerow GR; Cooper NR
    J Immunol; 1986 Jun; 136(11):4146-51. PubMed ID: 3009616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells.
    Cantaloube JF; Piechaczyk M; Calender A; Lenoir G; Minty A; Carrière D; Fischer E; Poncelet P
    Eur J Immunol; 1990 Feb; 20(2):409-16. PubMed ID: 1690137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
    Carel JC; Myones BL; Frazier B; Holers VM
    J Biol Chem; 1990 Jul; 265(21):12293-9. PubMed ID: 1695627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site.
    Myones BL; Ross GD
    Complement; 1987; 4(2):87-98. PubMed ID: 3497773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The generation of active fragments of complement receptor type 2 by trypsin digestion.
    Micklem K; Sim E; Sim RB
    FEBS Lett; 1985 Sep; 189(2):195-201. PubMed ID: 3876241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of the B-lymphocyte Epstein-Barr virus/C3d receptor.
    Nemerow GR; Moore MD; Cooper NR
    Adv Cancer Res; 1990; 54():273-300. PubMed ID: 2136962
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors.
    Edwards JE; Gaither TA; O'Shea JJ; Rotrosen D; Lawley TJ; Wright SA; Frank MM; Green I
    J Immunol; 1986 Dec; 137(11):3577-83. PubMed ID: 2946764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).
    Micklem KJ; Sim RB; Sim E
    Biochem J; 1984 Nov; 224(1):75-86. PubMed ID: 6239618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular interaction of EBV/C3d receptor (CR2) with p68, a calcium-binding protein present in normal but not in transformed B lymphocytes.
    Barel M; Gauffre A; Lyamani F; Fiandino A; Hermann J; Frade R
    J Immunol; 1991 Aug; 147(4):1286-91. PubMed ID: 1831222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.